Public Release: 

CNIC commits 5 million Euros to the Mount Sinai School of Medicine

Dr. Valentin Fuster spearheads aggressive scientific interrelations between Mount Sinai and CNIC to benefit cardiovascular research globally

The Mount Sinai Hospital / Mount Sinai School of Medicine

The Spanish Cardiovascular Research Center (Centro Nacional de Investigaciones Cardiovasculares Carlos III, commonly referred to as CNIC) today made a commitment in the amount of 5 million euros, which is nearly $6 million USD, to the Mount Sinai School of Medicine. The contribution will be used to fund the Valentin Fuster Laboratories, new research facilities at the Mount Sinai School of Medicine.

"The CNIC's goal is to become a Center of European and international excellence for basic and translational research in cardiovascular disease. A key factor in the CNIC's success will be its relationship with the medical research community around the world," states Valentin Fuster, M.D., Ph.D., Director of both the Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health at the Mount Sinai Medical Center, and the Richard Gorlin, MD/Heart Research Foundation Professor. "The CNIC is off to a great start with the new research facilities at the Mount Sinai Medical Center in New York, home of top minds in cardiology today. We look forward to growing the partnership."

The relationship between Dr. Fuster and the CNIC is not a new one. This past June, Spain's Ministry of Health asked Dr. Fuster to lead the research effort at the CNIC. With a strong allegiance to Spain, his homeland, Dr. Fuster took on the role of President of the Scientific Advisory and External Evaluation Committee while maintaining lead research duties at the Mount Sinai Medical Center in New York.

"This is a landmark partnership and the start of a global network for cardiovascular research," shares Dr. Fuster. "We have put into place a highly aggressive scientific interrelation between Mount Sinai and CNIC, as well as with other U.S. and European Centers."


The CNIC receives partial funding from the Spanish government and partial funding from thirteen large companies from the private sector. They have signed on to sustain the CNIC program financially through 2015.

Located in Manhattan, Mount Sinai School of Medicine is internationally recognized for ground-breaking clinical and basic-science research, and innovative approaches to medical education. Through the Mount Sinai Graduate School of Biological Sciences, Mount Sinai trains biomedical researchers with an emphasis on the rapid translation of discoveries of basic research into new techniques for fighting disease. One indication of Mount Sinai's leadership in scientific investigation is its receipt during fiscal year 2004 of $153.2 million. Mount Sinai now ranks 25th among the nation's medical schools in receipt of research support from NIH. Mount Sinai School of Medicine also is known for unique educational programs such as the Humanities in Medicine program, which creates opportunities for liberal arts students to pursue medical school, and instructional innovations like The Morchand Center, the nation's largest program teaching students and physicians with "standardized patients" to become not only highly skilled, but compassionate caregivers. Long dedicated to improving its community, the School extends its boundaries to work with East Harlem and surrounding communities to provide access to health care and educational programs to at risk populations.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.